Frequently Asked Questions...
This study is being conducted at medical centers around the country to compare two types of standard care radiation therapy: PHoton Therapy (pronounced “fo-tahn”) and PRoton Therapy (pronounced “pro-tahn”) — to find out which type of radiation is best for treating your type of breast cancer. Both treatments work and neither is experimental.
PHoton and PRoton therapy are both standard care radiation therapy treatments. Photon and Proton therapy deliver similar radiation doses to your chest wall, breast tissue, and immediate surrounding lymph node areas in front of the heart, above the collar bone, and/or below the armpit. The chart below compares each type of radiation. You may have side effects with either radiation treatment.
Why is the RadComp study needed?
Doctors do not know if one type of radiation, PHoton or PRoton therapy, is better, about the same, or worse in terms of side effects, cure rates, length of life or quality of life after radiation.
What do we hope to learn?
We want to learn if one type of radiation (PHoton or PRoton Therapy) is better at helping you live longer or have a better quality of life.
What is a pragmatic trial?
Pragmatic clinical trials are designed to test treatment options in real-world settings to increase value to patients.
What are the benefits of participating in the RadComp study?
Taking part in this study may or may not make your health better. You are not promised to experience any direct benefit from participating in this study, but your participation may shape the future of breast cancer treatment by helping determine which radiation therapy is best for patients with your type of breast cancer.
How can I participate in the RadComp study?
If you have been diagnosed with non-metastatic breast cancer and will be having radiation therapy, you may be eligible for this study.
Who is conducting the RadComp study?
The RadComp study is being conducted at medical centers across the country. To find a participating site near you, visit our site page.
How long is the RadComp study?
The total enrollment for this study is expected to take at least 5 years and then it will take approximately another 10 years to complete all analysis and reporting. If you decide to participate in this study you will be in the study until all the assessments are completed which will take about 10 years. Follow-up visits will be scheduled at 1 month, 6 months, and yearly from the end of radiation therapy. We will also call you every six months to check in about your health.
What is radiation therapy for breast cancer?
External beam radiation therapy is a cancer treatment that aims a beam (or many beams) of radiation through the skin to the breast or chest wall and the surrounding area to destroy cancer cells. When you receive radiation, a large machine aims the radiation and moves around you without touching you. Radiation therapy after surgery plays an important role in the treatment of breast cancer.
PHoton and PRoton therapy are both standard care radiation therapy treatments. Photon and Proton therapy deliver similar radiation doses to your chest wall, breast tissue, and immediate surrounding lymph node areas in front of the heart, above the collar bone, and/or below the armpit.
Is PHoton or PRoton therapy experimental?
No, neither PHoton nor PRoton therapy are experimental. Both are FDA-approved radiation treatments and are on the cutting-edge of cancer therapy.
Will my insurance company pay for PHoton or PRoton therapy?
You should check to see if the radiation treatments in this study are covered by your health insurance. If they are covered, you may still be responsible for some costs, such as co-pays and deductibles. If your insurance will not cover a specific radiation treatment and you still want to participate, you will be responsible for paying for radiation treatment you receive.
Why shouldn’t I just get PHoton or PRoton therapy off of the study?
Doctors do not know if one type of radiation is better, about the same, or worse in terms of side effects, cure rates, length of life or quality of life after radiation. By participating in the study, we will be monitoring your health long after radiation treatment. Your participation may also help decide which radiation therapy is best for future patients with your type of breast cancer.
Who is funding the RadComp study?
This research study is funded by the Patient-Centered Outcomes Research Institute (PCORI) (Contract # PCS-1403- 12804). PCORI is an independent, nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make better- informed healthcare decisions.
Where can I learn more about breast cancer clinical trials?
Please visit the following pages to learn more about breast cancer and clinical trials.
ClinicalTrials.gov — Learn About Clinical trials: https://www.clinicaltrials.gov/ct2/about-studies/learn
Susan G. Komen — Clinical Trials: http://ww5.komen.org/BreastCancer/ClinicalTrials.html
NIH — Clinical Trials and You: https://www.nih.gov/health-information/nih-clinical-research-trials-you
Oncolink — All About Breast Cancer: http://www.oncolink.org/cancers/breast/all-about-breast-cancer